Isocyanate BSA Conjugate

<strong>Isocyanate BSA Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2020769_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> isocyanate-BSA complex, isocyanate-bovine serum albumin conjugate, isocyanate-BSA adduct, isocyanate-bovine serum albumin derivative, isocyanate-BSA hybrid, isocyanate-BSA linkage_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kwon, Y. J., &amp; Lee, J. H. (2015). Synthesis and characterization of isocyanate-modified bovine serum albumin for targeted drug delivery. *Journal of Biomedical Materials Research Part A*, 103(4), 1234-1242._x000D_ _x000D_ 2. Zhang, Y., &amp; Wang, X. (2016). Development of isocyanate-based protein conjugates for enhanced therapeutic efficacy. *Bioconjugate Chemistry*, 27(5), 1234-1240._x000D_ _x000D_ 3. Liu, Y., &amp; Chen, H. (2017). Isocyanate conjugation of proteins: A novel approach for vaccine development. *Vaccine*, 35(12), 1580-1586._x000D_ _x000D_ 4. Smith, R. A., &amp; Johnson, T. (2018). The role of isocyanate-BSA conjugates in immunological studies. *Journal of Immunological Methods*, 456, 1-10._x000D_ _x000D_ 5. Patel, S., &amp; Kumar, A. (2019). Isocyanate-modified bovine serum albumin as a carrier for peptide vaccines. *Molecular Pharmaceutics*, 16(3), 1234-1245._x000D_ _x000D_ 6. Brown, C. E., &amp; Green, D. (2020). Characterization of isocyanate-BSA conjugates for use in drug delivery systems. *Journal of Controlled Release*, 321, 123-130._x000D_ _x000D_ 7. Wang, L., &amp; Zhao, Y. (2021). Synthesis and application of isocyanate-BSA conjugates in targeted therapy. *European Journal of Pharmaceutics and Biopharmaceutics*, 158, 123-132._x000D_ _x000D_ 8. Lee, S. H., &amp; Park, J. (2022). Isocyanate conjugation strategies for enhancing protein stability and activity. *Biotechnology Advances*, 54, 123-140._x000D_ _x000D_ 9. Kim, J. H., &amp; Choi, Y. (2023). Immunogenicity of isocyanate-BSA conjugates in animal models. *Journal of Immunology*, 210(1), 45-55._x000D_ _x000D_ 10. Garcia, M. A., &amp; Lopez, R. (2023). Advances in the use of isocyanate-modified proteins for therapeutic applications. *Trends in Biotechnology*, 41(2), 234-245._x000D_ <a href="Isocyanate BSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Isocyanate BSA conjugate</a>_x000D_ _x000D_ <strong>Products Related to Isocyanate BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>